Stockscreener 앱 받기
100.97
0.01%
-0.01
전일 마감가:
$100.98
열려 있는:
$100.75
하루 거래량:
833.22K
Relative Volume:
0.64
시가총액:
$6.59B
수익:
$1.54B
순이익/손실:
$233.56M
주가수익비율:
29.99
EPS:
3.3669
순현금흐름:
$348.64M
1주 성능:
+0.20%
1개월 성능:
-0.14%
6개월 성능:
+29.71%
1년 성능:
+87.61%
1일 변동 폭
$100.75
$101.00
1주일 범위
$100.54
$101.43
52주 변동 폭
$49.67
$111.86
Lantheus Holdings Inc Stock (LNTH) Company Profile
명칭
Lantheus Holdings Inc
전화
978 671-8001
주소
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
100.97 | 6.54B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | 업그레이드 | Truist | Hold → Buy |
| 2025-10-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-08-12 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-18 | 개시 | Goldman | Buy |
| 2024-09-03 | 개시 | Redburn Atlantic | Buy |
| 2024-07-10 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-12-18 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | 개시 | TD Cowen | Outperform |
| 2023-09-29 | 개시 | William Blair | Outperform |
| 2023-03-08 | 개시 | JMP Securities | Mkt Outperform |
| 2022-11-30 | 개시 | SVB Leerink | Outperform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-05-09 | 개시 | B. Riley Securities | Buy |
| 2022-04-13 | 개시 | Truist | Buy |
| 2021-02-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-29 | 재개 | Jefferies | Buy |
| 2019-08-16 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-09-23 | 재개 | Credit Suisse | Neutral |
| 2016-02-24 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-12-11 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | 개시 | Credit Suisse | Outperform |
| 2015-07-20 | 개시 | Jefferies | Buy |
| 2015-07-20 | 개시 | RBC Capital Mkts | Outperform |
| 2015-07-20 | 개시 | Robert W. Baird | Outperform |
| 2015-07-20 | 개시 | Wells Fargo | Outperform |
모두보기
Lantheus Holdings Inc 주식(LNTH)의 최신 뉴스
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) - Yahoo Finance
Lantheus (LNTH) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in Latest Trading; Session Move - Vinanet
Lantheus Holdings CAO Kimberly Brown Sells 463 Shares for Tax Withholding Purposes - Kalkine Media
Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% Upside - TradingView
Lantheus (LNTH) Q2 2026 Filing Snapshot: The EPS Result Is Above Expectation in the Current Update; Market Follow-Through: The Stock Records a 0.64% Decrease on the DayInvestor Earnings Call - Vinanet
Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com
B.Riley downgrades Lantheus stock rating on Curium acquisition By Investing.com - Investing.com Australia
B.Riley downgrades Lantheus stock rating on Curium acquisition - Investing.com Nigeria
FDA approves Lantheus tau PET imaging agent for Alzheimer’s disease - DOTmed
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside - DirectorsTalk Interviews
Tauklarify PET approval for Lantheus in AD NFT pathology - pharmaphorum
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Sahm
Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals - RTTNews
US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment - KWSN
LNTH Looks 10.1% Overvalued on GF Value™ - GuruFocus
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters
Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify - marketscreener.com
Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s - Seeking Alpha
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease - Investing.com
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease By Investing.com - Investing.com Nigeria
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease - The Manila Times
FDA approves Lantheus brain scan to identify tau in Alzheimer’s - Stock Titan
Farallon group (LNTH) discloses 5.58M-share, 8.6% position in Lantheus - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
(LNTH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insuran - WBOC TV
Pacer Advisors Inc. Reduces Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings: Why I Am Exiting Before The Merger Closes (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio - DirectorsTalk Interviews
Empowered Funds LLC Takes Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. $LNTH is Reinhart Partners LLC.'s 2nd Largest Position - MarketBeat
Assenagon Asset Management S.A. Raises Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus (LNTH) Stock Shrugs Off Solid Profit As Margin Questions Linger - Sahm
Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPS - MarketBeat
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc.LNTH - Business Wire
Form 8K Lantheus Holdings Inc For: 6 August By Investing.com - Investing.com South Africa
LNTH Looks 12.1% Overvalued on GF Value™ - GuruFocus
Lantheus Holdings, Inc. Suspends its Previously Issued Full Year 2026 Financial Guidance - marketscreener.com
Lantheus Holdings Inc earnings beat by $0.26, revenue topped estimates - Investing.com
Lantheus' Q2 Adjusted Earnings Fall, Revenue Rises - marketscreener.com
Lantheus Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Is Lantheus Holdings Inc (LNTH) Overvalued Despite Q2 Earnings M - GuruFocus
LNTH: Q2 2026 saw revenue growth, strategic acquisitions, and a pending merger with Curium - TradingView
Earnings Flash (LNTH) Lantheus Holdings, Inc. Reports Q2 Revenue $388.2M, vs. FactSet Est of $363.2M - marketscreener.com
Earnings Flash (LNTH) Lantheus Holdings, Inc. Posts Q2 Adjusted EPS $1.55 per Share, vs. FactSet Est of $1.30 - marketscreener.com
Lantheus Q2 revenue rises to $388.2 million - Quiver Quantitative
Lantheus Holdings: Q2 Earnings Snapshot - Barchart.com
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026 - Yahoo Finance
Lantheus Reports Second Quarter 2026 Financial Results - marketscreener.com
Press Release: Lantheus Reports Second Quarter 2026 Financial Results - Moomoo
Lantheus Holdings Inc (LNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lantheus Holdings Inc 주식 (LNTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings, Inc. | 10% Owner |
Sep 01 '26 |
Sale |
3.12 |
35,769 |
111,574 |
11,563,425 |
| Lantheus Holdings, Inc. | 10% Owner |
Aug 31 '26 |
Sale |
3.14 |
78,145 |
245,610 |
11,599,194 |
1.66%
0.33%
자본화:
|
볼륨(24시간):